Tekla Life Sciences Investors (NYSE:HQL)

16.16
Delayed Data
As of Aug 16
 -0.15 / -0.92%
Today’s Change
13.03
Today|||52-Week Range
22.70
-15.96%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2016

2017

2018

--
AssetsCash10.1K615.3K41.00--
 
 
 
 
Cash & Short Term Investments9.9M10.2M13.1M--
 
 
 
 
 
ReceivablesReceivables9.9M18.1K11.2M--
 
 
 
 
 
InventoriesInventories0.000.000.00----
 
Current AssetsCurrent Assets----------
 
Total AssetsOther Assets400.2K719.4K825.4K--
 
 
 
 
Total Assets417.6M468.3M478.5M--
 
 
 
 
 
LiabilitiesAccrued Expenses170.5K185.6K155.2K--
 
 
 
 
Other Liabilities----------
 
Total LiabilitiesOther Liabilities2.7M2.0M3.0M--
 
 
 
 
Total Liabilities2.7M2.0M3.0M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.00----
Common Equity415.0M466.4M475.5M--
 
 
 
 
Total Shareholder Equity415.0M466.4M475.5M--
 
 
 
 
 
Share InformationCommon Shares Outstanding20.7M21.6M22.4M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.